You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
蔚藍生物(603739.SH):積極探索AI智能改造技術在酶蛋白優化改良、菌株代謝通路優化和智能發酵調控中的應用

格隆匯6月10日丨蔚藍生物(603739.SH)在投資者互動平臺表示,公司在合成生物領域僅設立了1個合成生物技術創新實驗室,主要用於研發飼料用功能性蛋白、食品用甜味劑等。但該實驗室儲備的研發項目少、投入金額小、專業人員配置少,目前仍處於前期菌種實驗室研發階段,距離規模化放大還有較大差距,並不具備產業化條件。合成生物學產品的生產涉及分離、提純等生產工藝,且提純工藝難度較大,公司目前尚不具備該工藝,有待進一步開發。同時,產品未來還可能涉及註冊及法規審批、選品及市場推廣等,週期較長,難度較大,商業化存在重大的不確定性。預計在較長的時間,不會對公司的經營產生重大的影響。除此之外,公司不涉及其他合成生物領域的研發投入。 公司已構建里氏木黴、畢赤酵母、黑麴黴、芽孢桿菌四大高效蛋白質表達系統,並建立了相應的規模化發酵體系。同時,公司搭建了行業領先的高通量篩選工作站,構建了通用型高通量基因篩選大數據模型及蛋白質工程改造等核心技術體系,大幅提升了酶製劑的催化效率和工業應用性能,進一步增強了生物產業的技術創新能力。 公司積極探索AI智能改造技術在酶蛋白優化改良、菌株代謝通路優化和智能發酵調控中的應用,已成立AI技術開發及應用實驗室,並圍繞相關技術與企業開展合作及交流,研討生物智能製造大模型研發平臺的可行性,穩步推進AI技術在酶蛋白功能特性優化、酶蛋白質高效表達的代謝網絡調控及菌種智能發酵優化等領域的探索與實踐。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account